173 related articles for article (PubMed ID: 36245013)
1. A quantitative characterization of the spatial distribution of brain metastases from breast cancer and respective molecular subtypes.
Mahmoodifar S; Pangal DJ; Cardinal T; Craig D; Simon T; Tew BY; Yang W; Chang E; Yu M; Neman J; Mason J; Toga A; Salhia B; Zada G; Newton PK
J Neurooncol; 2022 Oct; 160(1):241-251. PubMed ID: 36245013
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
[TBL] [Abstract][Full Text] [Related]
3. The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
Cho E; Rubinstein L; Stevenson P; Gooley T; Philips M; Halasz LM; Gensheimer MF; Linden HM; Rockhill JK; Gadi VK
Breast Cancer Res Treat; 2015 Feb; 149(3):743-9. PubMed ID: 25638395
[TBL] [Abstract][Full Text] [Related]
4. Impact of breast cancer subtype on clinical outcomes after Gamma Knife radiosurgery for brain metastases from breast cancer: a multi-institutional retrospective study (JLGK1702).
Aoyagi K; Higuchi Y; Matsunaga S; Serizawa T; Yomo S; Aiyama H; Nagano O; Kondoh T; Kenai H; Shuto T; Kawagishi J; Jokura H; Sato S; Nakazaki K; Nakaya K; Hasegawa T; Kawashima M; Kawai H; Yamanaka K; Nagatomo Y; Yamamoto M; Sato Y; Aoyagi T; Matsutani T; Iwadate Y
Breast Cancer Res Treat; 2020 Nov; 184(1):149-159. PubMed ID: 32737714
[TBL] [Abstract][Full Text] [Related]
5. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
[TBL] [Abstract][Full Text] [Related]
6. New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2021 Apr; 186(2):453-462. PubMed ID: 33392845
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study.
Kaidar-Person O; Meattini I; Jain P; Bult P; Simone N; Kindts I; Steffens R; Weltens C; Navarria P; Belkacemi Y; Lopez-Guerra J; Livi L; Baumert BG; Vieites B; Limon D; Kurman N; Ko K; Yu JB; Chiang V; Poortmans P; Zagar T
Breast Cancer Res Treat; 2018 Jan; 167(2):479-483. PubMed ID: 28975433
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer brain metastases - A 12 year review of treatment outcomes.
De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
[TBL] [Abstract][Full Text] [Related]
9. Volumetric modulated arc radiosurgery for brain metastases from breast cancer: A single-center study.
Sánchez-Villalobos JM; Serna-Berna A; Salinas-Ramos J; Escolar-Pérez PP; Martínez-Alonso E; Achel DG; Alcaraz M
Colomb Med (Cali); 2021; 52(3):e2004567. PubMed ID: 35382414
[TBL] [Abstract][Full Text] [Related]
10. Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
Neman J; Franklin M; Madaj Z; Deshpande K; Triche TJ; Sadlik G; Carmichael JD; Chang E; Yu C; Strickland BA; Zada G
J Neurosurg; 2022 Jan; 136(1):88-96. PubMed ID: 34271545
[TBL] [Abstract][Full Text] [Related]
11. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
Yomo S; Hayashi M; Cho N
J Neurooncol; 2013 Apr; 112(2):199-207. PubMed ID: 23296546
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases originating in breast cancer: clinical-pathological analysis and immunohistochemical profile.
Sava A; Costea CF; Vatavu R; Grigore M; Turliuc MD; Dumitrescu GF; Eva L; Motoc AGM; Stan CI; Gavril LC; Scripcariu SI
Rom J Morphol Embryol; 2021; 62(2):435-444. PubMed ID: 35024731
[TBL] [Abstract][Full Text] [Related]
14. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.
Sperduto PW; Kased N; Roberge D; Chao ST; Shanley R; Luo X; Sneed PK; Suh J; Weil RJ; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
J Neurooncol; 2013 May; 112(3):467-72. PubMed ID: 23462853
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models.
Mahmoodifar S; Pangal DJ; Neman J; Zada G; Mason J; Salhia B; Kaisman-Elbaz T; Peker S; Samanci Y; Hamel A; Mathieu D; Tripathi M; Sheehan J; Pikis S; Mantziaris G; Newton PK
J Neurooncol; 2024 May; 167(3):501-508. PubMed ID: 38563856
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
17. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
18. Subtypes of breast cancer show different spatial distributions of brain metastases.
Kyeong S; Cha YJ; Ahn SG; Suh SH; Son EJ; Ahn SJ
PLoS One; 2017; 12(11):e0188542. PubMed ID: 29155879
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer subtypes and survival in patients with brain metastases.
Nam BH; Kim SY; Han HS; Kwon Y; Lee KS; Kim TH; Ro J
Breast Cancer Res; 2008; 10(1):R20. PubMed ID: 18307763
[TBL] [Abstract][Full Text] [Related]
20. Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer.
Bachmann C; Grischke EM; Staebler A; Schittenhelm J; Wallwiener D
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1909-16. PubMed ID: 24037487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
